CRDL
Price
$1.08
Change
+$0.01 (+0.93%)
Updated
Aug 7 closing price
Capitalization
124.33M
10 days until earnings call
LNTH
Price
$54.86
Change
+$2.99 (+5.76%)
Updated
Aug 7 closing price
Capitalization
4.27B
83 days until earnings call
Interact to see
Advertisement

CRDL vs LNTH

Header iconCRDL vs LNTH Comparison
Open Charts CRDL vs LNTHBanner chart's image
Cardiol Therapeutics
Price$1.08
Change+$0.01 (+0.93%)
Volume$1.21M
Capitalization124.33M
Lantheus Holdings
Price$54.86
Change+$2.99 (+5.76%)
Volume$3.9M
Capitalization4.27B
CRDL vs LNTH Comparison Chart in %
Loading...
CRDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRDL vs. LNTH commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRDL is a Hold and LNTH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (CRDL: $1.09 vs. LNTH: $54.86)
Brand notoriety: CRDL and LNTH are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CRDL: 281% vs. LNTH: 280%
Market capitalization -- CRDL: $124.33M vs. LNTH: $4.27B
CRDL [@Pharmaceuticals: Other] is valued at $124.33M. LNTH’s [@Pharmaceuticals: Other] market capitalization is $4.27B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRDL’s FA Score shows that 0 FA rating(s) are green whileLNTH’s FA Score has 0 green FA rating(s).

  • CRDL’s FA Score: 0 green, 5 red.
  • LNTH’s FA Score: 0 green, 5 red.
According to our system of comparison, LNTH is a better buy in the long-term than CRDL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRDL’s TA Score shows that 5 TA indicator(s) are bullish while LNTH’s TA Score has 4 bullish TA indicator(s).

  • CRDL’s TA Score: 5 bullish, 5 bearish.
  • LNTH’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CRDL is a better buy in the short-term than LNTH.

Price Growth

CRDL (@Pharmaceuticals: Other) experienced а -27.18% price change this week, while LNTH (@Pharmaceuticals: Other) price change was -22.94% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.12%. For the same industry, the average monthly price growth was +73.14%, and the average quarterly price growth was +82.67%.

Reported Earning Dates

CRDL is expected to report earnings on Aug 18, 2025.

LNTH is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.12% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LNTH($4.27B) has a higher market cap than CRDL($124M). CRDL YTD gains are higher at: -15.234 vs. LNTH (-38.677). LNTH has higher annual earnings (EBITDA): 491M vs. CRDL (-30.61M). LNTH has more cash in the bank: 714M vs. CRDL (40.5M). CRDL has less debt than LNTH: CRDL (181K) vs LNTH (617M). LNTH has higher revenues than CRDL: LNTH (1.3B) vs CRDL (0).
CRDLLNTHCRDL / LNTH
Capitalization124M4.27B3%
EBITDA-30.61M491M-6%
Gain YTD-15.234-38.67739%
P/E RatioN/A12.93-
Revenue01.3B-
Total Cash40.5M714M6%
Total Debt181K617M0%
FUNDAMENTALS RATINGS
CRDL vs LNTH: Fundamental Ratings
CRDL
LNTH
OUTLOOK RATING
1..100
753
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
59
Fair valued
PROFIT vs RISK RATING
1..100
10060
SMR RATING
1..100
10040
PRICE GROWTH RATING
1..100
9094
P/E GROWTH RATING
1..100
10064
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LNTH's Valuation (59) in the Medical Specialties industry is somewhat better than the same rating for CRDL (96) in the null industry. This means that LNTH’s stock grew somewhat faster than CRDL’s over the last 12 months.

LNTH's Profit vs Risk Rating (60) in the Medical Specialties industry is somewhat better than the same rating for CRDL (100) in the null industry. This means that LNTH’s stock grew somewhat faster than CRDL’s over the last 12 months.

LNTH's SMR Rating (40) in the Medical Specialties industry is somewhat better than the same rating for CRDL (100) in the null industry. This means that LNTH’s stock grew somewhat faster than CRDL’s over the last 12 months.

CRDL's Price Growth Rating (90) in the null industry is in the same range as LNTH (94) in the Medical Specialties industry. This means that CRDL’s stock grew similarly to LNTH’s over the last 12 months.

LNTH's P/E Growth Rating (64) in the Medical Specialties industry is somewhat better than the same rating for CRDL (100) in the null industry. This means that LNTH’s stock grew somewhat faster than CRDL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRDLLNTH
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
71%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
66%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 7 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CRDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FPUKX26.06N/A
N/A
Fidelity Puritan K
IBSAX14.11N/A
N/A
VY® Baron Growth A
FAOFX18.94N/A
N/A
Fidelity Advisor Series Growth Opps
VEOAX27.40N/A
N/A
Vanguard Global Environmental Opp StkAdm
CVTRX52.96-0.03
-0.06%
Calamos Growth & Income A

CRDL and

Correlation & Price change

A.I.dvisor tells us that CRDL and TLRY have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRDL and TLRY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDL
1D Price
Change %
CRDL100%
+1.40%
TLRY - CRDL
32%
Poorly correlated
+5.40%
LNTH - CRDL
32%
Poorly correlated
+5.76%
SCYX - CRDL
30%
Poorly correlated
+23.41%
ACB - CRDL
30%
Poorly correlated
-0.59%
EOLS - CRDL
29%
Poorly correlated
-4.71%
More

LNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, LNTH has been loosely correlated with EOLS. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if LNTH jumps, then EOLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LNTH
1D Price
Change %
LNTH100%
+5.76%
EOLS - LNTH
33%
Loosely correlated
-4.71%
ACET - LNTH
32%
Poorly correlated
-1.97%
SNDL - LNTH
26%
Poorly correlated
-1.18%
LFCR - LNTH
24%
Poorly correlated
+0.39%
ORGO - LNTH
24%
Poorly correlated
+0.44%
More